|Videos|October 11, 2016
Identifying the Appropriate Patients for Atopic Dermatitis Treatments
Advertisement
Episodes in this series
Panelists Peter L. Salgo, MD; Cheryl Allen, BS Pharm, MBA; Ed Pezalla, MD, MPH; Jonathan Silverberg, MD, PhD, MPH; and Jeffrey D. Dunn, PharmD, MBA, discuss factors in identifying appropriate patients for specific atopic dermatitis treatments.
Advertisement
Related to this article
BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
2
FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL
3
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
4
Increasing Daily Steps Matches Aerobic Training for Asthma Control in Randomized Trial
5